OrbiMed
Tracked across 5 events · 50 articles · First seen Mar 17, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: OrbiMed led a $32 million funding round for Pee Safe, becoming a key investor and facilitating the exit of early-stage investors.
Mar 17, 2026 · 6 articles
Business
Impact: OrbiMed invested in Iswarya, extending its India portfolio into fertility care, reflecting confidence in the sector's growth.
Jul 09, 2026 · 7 articles
Business
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: OrbiMed participated in the private placement financing.
Aug 17, 2026 · 6 articles
Business
Impact: Healthcare investment firm; suggests Novo needs deals to compete long-term.
Aug 03, 2026 · 6 articles
Business
Impact: OrbiMed is a venture backer of Scribe. The IPO provides a return on their investment.
Jul 06, 2026 · 25 articles
ERGEN INTELLIGENCE
Track OrbiMed live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard